1. Home
  2. DAR vs HALO Comparison

DAR vs HALO Comparison

Compare DAR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Darling Ingredients Inc.

DAR

Darling Ingredients Inc.

HOLD

Current Price

$63.21

Market Cap

9.7B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$77.93

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAR
HALO
Founded
1882
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.1B
IPO Year
2002
2001

Fundamental Metrics

Financial Performance
Metric
DAR
HALO
Price
$63.21
$77.93
Analyst Decision
Strong Buy
Buy
Analyst Count
11
11
Target Price
$65.82
$78.64
AVG Volume (30 Days)
2.4M
1.8M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
1.22
Revenue
$6,135,877,000.00
$151,862,000.00
Revenue This Year
$7.78
$28.24
Revenue Next Year
$3.37
$12.56
P/E Ratio
$73.69
$63.51
Revenue Growth
7.36
N/A
52 Week Low
$29.15
$55.64
52 Week High
$66.02
$82.26

Technical Indicators

Market Signals
Indicator
DAR
HALO
Relative Strength Index (RSI) 67.78 59.64
Support Level $56.74 $67.12
Resistance Level $63.95 $82.24
Average True Range (ATR) 1.86 2.47
MACD 0.78 -0.32
Stochastic Oscillator 98.90 48.74

Price Performance

Historical Comparison
DAR
HALO

About DAR Darling Ingredients Inc.

Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: